# ClinicalTrials.gov record NCT03796884

> PeptideScanner retained ClinicalTrials.gov record NCT03796884 at 2026-08-10T18:10:04.224Z. Its registry update date was 2026-07-22, and PeptideScanner's reviewed identity mapping was linaclotide.

- Evidence object: `story:clinicaltrials-gov-nct03796884-linaclotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-22
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03796884-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03796884-linaclotide-v1.json
- Content SHA-256: `af65a95616134d38f6044131274c139d577914242871f5b634073b2ee5a20de4`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT03796884 ([`ctg-observation-nct03796884-2026-07-22-fb310d5da688`](#source-ctg-observation-nct03796884-2026-07-22-fb310d5da688))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03796884 at 2026-08-10T18:10:04.224Z. Its registry update date was 2026-07-22, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct03796884-2026-07-22-fb310d5da688`](#source-ctg-observation-nct03796884-2026-07-22-fb310d5da688))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03796884 at 2026-08-10T18:10:04.224Z. Its registry update date was 2026-07-22, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct03796884-2026-07-22-fb310d5da688`](#source-ctg-observation-nct03796884-2026-07-22-fb310d5da688))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03796884-2026-07-22-fb310d5da688`](#source-ctg-observation-nct03796884-2026-07-22-fb310d5da688))

## Sources

<a id="source-ctg-observation-nct03796884-2026-07-22-fb310d5da688"></a>
- **ClinicalTrials.gov record NCT03796884 · retained source version 2026-07-22:fb310d5da68866e030991ed3c74ab6d9270e93f4581d0a02cc6a7a6bc9b51825** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03796884) (`ctg-observation-nct03796884-2026-07-22-fb310d5da688`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03796884." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03796884-linaclotide-v1.json SHA-256: af65a95616134d38f6044131274c139d577914242871f5b634073b2ee5a20de4.